SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 31, 17:00
632.10
8.35 (1.34%)
VOLUME 120,597
LIVE
NSE
Oct 31, 17:00
633.35
10.05 (1.61%)
VOLUME 813,121
News on Ranbaxy Laboratories
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Brace for more new mkt highs in days to come: Raamdeo 

5.05 pm | 30 Oct 2014 |  Source: CNBC-TV18

Commenting the market’s move, Raamdeo Agrawal, joint managing director, Motilal Oswal, said the recent selling for foreign investors had abated and ...

Time to revamp portfolio; like NBFCs, banks: Dipan Mehta 

9.11 am | 30 Oct 2014 |  Source: CNBC-TV18

Dipan Mehta, member BSE and NSE says by and large tech and pharma companies have disappointed this earnings season....

Buy Ranbaxy Laboratories, says Sukhani 

11.19 am | 29 Oct 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com advises buying Ranbaxy Laboratories at current levels....

Hold Ranbaxy Laboratories, says Prakash Agarwal 

9.43 am | 29 Oct 2014 |  Source: CNBC-TV18

According to Prakash Agarwal, Equity Analyst at CIMB, one may hold Ranbaxy Laboratories....

US core business continues to be a drag for Ranbaxy: CIMB 

9.05 am | 29 Oct 2014 |  Source: CNBC-TV18

Prakash Agarwal, Equity Analyst, CIMB has a hold rating on Ranbaxy with target price of Rs 630/share. ...

Top 10 stocks to keep an eye on October 29 

8.36 am | 29 Oct 2014 |  Source: CNBC-TV18

Here are Top 10 stocks to focus on October 29 - HDFC, Crompton Greaves, ING Vysya, Jubilant Life, Nestle, Ranbaxy, PI Industries, CCL Prod, SRF, VST I...

Stocks in news: Hero, Dr Reddy's Labs, ONGC, BHEL, SRF, SBT

8.28 am | 29 Oct 2014 |  Source: CNBC-TV18

Hero Motocorp | State Bank of India | Dr Reddy's Labs | ONGC | BHEL | Ranbaxy Labs | Jubilant Life | ING Vysya Bank | SRF | CCL Products | PI Industri...

Here's how experts read Ranbaxy's Q2FY15 earnings

3.59 pm | 28 Oct 2014 |  Source: CNBC-TV18

Ranbaxy Laboratories has turned profitable in the second quarter of current financial year. The company reported consolidated net profit of Rs 478 cro...

Ranbaxy turns corner, Q2 net at Rs 478 cr; OPM up 1770 bps 

2.02 pm | 28 Oct 2014 |  Source: Moneycontrol.com

The company reported consolidated net profit of Rs 478 crore during the quarter as against loss of Rs 454 crore in the year-ago period....

Buy Lupin above Rs 1400, says CK Narayan 

11.10 am | 28 Oct 2014 |  Source: CNBC-TV18

CK Narayan, Managing Director at Growth Avenues is of the view that one may buy Lupin above Rs 1400....

Bank Nifty to sustain recent gains; buy on dips: CK Narayan 

9.47 am | 28 Oct 2014 |  Source: CNBC-TV18

The Bank Nifty seems resilient and more willing to sustain gains made over the last week, says CK Narayan of Growth Avenues. Furthermore, he advises i...

Stocks in news: JSW Steel, Lupin, State Bank of Mysore

8.32 am | 28 Oct 2014 |  Source: CNBC-TV18

Coal India | JSW Steel | Thomas Cook | Essar India | Jindal Steel | Lupin | Ranbaxy Labs | ING Vysya Bank | State Bank Of Mysore | Bharti Infratel | A...

Nifty to open with marginal gains ahead of FOMC meet today

7.52 am | 28 Oct 2014 |  Source: Moneycontrol.com

US markets closed flat ahead of the FOMC meet that begins today. The Fed is expected to wrap up its third round of bond buying. Meanwhile, Asian marke...

Ranbaxy Labs gains 1% on litigation settlement with Texas

9.47 am | 16 Oct 2014 |  Source: Moneycontrol.com

Under the settlement agreement, Ranbaxy, which will soon become a subsidiary of Sun Pharma, will pay USD 39.75 million to State of Texas in a series o...

Ranbaxy Laboratories settles litigation; will pay USD 39.75mn to State of Texas

9.42 am | 16 Oct 2014 |  Source: Moneycontrol.com

Ranbaxy Laboratories Ltd has informed BSE that Ranbaxy has settled the litigation concerning its participation in the Texas Medicaid Program. Under th...

Ranbaxy Laboratories: Updates on termination of GDR programme

9.38 am | 16 Oct 2014 |  Source: Moneycontrol.com

Ranbaxy Laboratories Ltd has informed BSE that the Company has notified the Bank of New York Mellon (hereinafter ...

India-targeted M&As touch $21.7 bn: Mergermarket

4.08 pm | 14 Oct 2014 |  Source: PTI

The value of India-targeted M&A for the entire 2014 is likely to surpass the 2013 annual total of USD 22.3 billion, said the global deal tracking firm...

Stocks in news: Reliance Ind, DLF, Bajaj Auto, IL&FS Engg

8.19 am | 14 Oct 2014 |  Source: CNBC-TV18

Reliance Industries | DLF | Bajaj Auto | Liberty Shoes | IL&FS Engineering | Tata Power | Ranbaxy Labs | UCO Bank | UPL | Novartis India and Tata Stee...

Here's why pharma sector will continue outperforming

2.53 pm | 11 Oct 2014 |  Source: Moneycontrol.com

Analysts at Motilal Oswal believe that Lupin, Ranbaxy, Cadila Healthcare, GSK Pharma, Torrent Pharma and Alembic Pharma will report stronger overall o...

Sun Pharma expects Ranbaxy turnaround by FY19 

5.27 pm | 07 Oct 2014 |  Source: CNBC-TV18

Sun Pharma has begun the process of putting in place a strategy to turnaround Ranbaxy once the company gets the requisite regulatory nod by the end of...

1 2 3 4 5
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.